Abstract
International Journal of DermatologyVolume 24, Issue 7 p. 435-436 Topical Corticosteroids Lawrence Charles Parish M.D., Corresponding Author Lawrence Charles Parish M.D. Departments of Dermatology, Jefferson Medical College of the Thomas Jefferson University and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and the Division of New Product Development, Glaxo Inc., Research Triangle Park, North CarolinaAddress for correspondence: Lawrence Charles Parish, M.D., 1601 Walnut Street, Philadelphia, PA 19102.Search for more papers by this authorJoseph A. Witkowski M.D., Joseph A. Witkowski M.D. Departments of Dermatology, Jefferson Medical College of the Thomas Jefferson University and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and the Division of New Product Development, Glaxo Inc., Research Triangle Park, North CarolinaSearch for more papers by this authorJ. Gordon Muir M.D., J. Gordon Muir M.D. Departments of Dermatology, Jefferson Medical College of the Thomas Jefferson University and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and the Division of New Product Development, Glaxo Inc., Research Triangle Park, North CarolinaSearch for more papers by this author Lawrence Charles Parish M.D., Corresponding Author Lawrence Charles Parish M.D. Departments of Dermatology, Jefferson Medical College of the Thomas Jefferson University and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and the Division of New Product Development, Glaxo Inc., Research Triangle Park, North CarolinaAddress for correspondence: Lawrence Charles Parish, M.D., 1601 Walnut Street, Philadelphia, PA 19102.Search for more papers by this authorJoseph A. Witkowski M.D., Joseph A. Witkowski M.D. Departments of Dermatology, Jefferson Medical College of the Thomas Jefferson University and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and the Division of New Product Development, Glaxo Inc., Research Triangle Park, North CarolinaSearch for more papers by this authorJ. Gordon Muir M.D., J. Gordon Muir M.D. Departments of Dermatology, Jefferson Medical College of the Thomas Jefferson University and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, and the Division of New Product Development, Glaxo Inc., Research Triangle Park, North CarolinaSearch for more papers by this author First published: September 1985 https://doi.org/10.1111/j.1365-4362.1985.tb05812.xCitations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume24, Issue7September 1985Pages 435-436 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
